Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT
Clinical trial NCT03777982 · TERMINATED
Trial details
- NCT number
- NCT03777982
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-20
- Primary completion
- 2024-02-13
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.